October 26, 2020
Bioprocess Insider editor Dan Stanton joins an industry panel to discuss supply chain concerns stemming from the ongoing coronavirus crisis. Listen to the podcast now.
Brought to you by international pharmaceutical content, digital and design agency ramarketing, the Molecule to Market podcast takes a listen to the contract outsourcing space with industry insights direct from the brains of the people that make the headlines.
Image: iStock/style-photography
In this special episode, one of the headline writers – Bioprocess Insider founder and editor Dan Stanton – joins host Raman Sehgal, founder & global president at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, and Stefano Console, senior advisor and founder at Oriento, to discuss the past, present, and future of the pharma and bio supply chain.
Listen below to better understand how COVID-19 is driving unparalleled demand for therapies, vaccines, and the equipment needed to make these, and how geo-political concerns are leading nations and companies to rethink the global supply chain model across the biopharma sector.
If you enjoyed this and want to hear more regarding the ins and outs of the drug development industry from early phase discovery to commercial supply, subscribe to the Molecule to Market podcast here.
You May Also Like
